$2.3MSeed, 26 November 2025
Funds strengthen discovery and translational research to build the preclinical package for lead assets.
- Amount
- $2.3M
- Stage
- Seed
- Announced
- 26 November 2025
- Lead
- Octalfa
- Other investors
- Relyens Innovation Santé, Gilles Alberici, Armand Bensussan
- Use of funds
- Funds strengthen discovery and translational research to build the preclinical package for lead assets.
- Checked
- Announced by the company
- Sources
- Ventuno Biotech raises 3 million euros for preclinical development ventuno-biotech.com
Ventuno Biotech raises 3 million euros for preclinical development maddyness.com